ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,897Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 337

$591K Total Retail Price of All Prescriptions

Rank: 49 out of 337

475 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 475 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 593 519 1 1
AMLODIPINE BESYLATE 430 428 2 3
LISINOPRIL 353 288 3 2
TRAZODONE HCL 348 337 4 16
OMEPRAZOLE 336 258 5 4
FUROSEMIDE 312 291 6 8
WARFARIN SODIUM 296 282 7 11
LEVOTHYROXINE SODIUM 283 258 8 5
METOPROLOL SUCCINATE 281 277 9 21
METOPROLOL TARTRATE 273 244 10 6
GABAPENTIN 267 233 11 20
ATORVASTATIN CALCIUM 239 200 12 7
METFORMIN HCL 218 176 13 12
ATENOLOL 190 178 14 10
SERTRALINE HCL 176 143 15 18
POTASSIUM CHLORIDE 166 154 16 62
MIRTAZAPINE 163 149 17 27
ADVAIR DISKUS 161 148 18 44
DONEPEZIL HCL 160 160 19 22
ENALAPRIL MALEATE 153 146 20 37
HYDROCHLOROTHIAZIDE 140 134 21 9
HYDROCODONE-ACETAMINOPHEN 133 60 S3 22 13
AZITHROMYCIN 122 104 23 51
NAMENDA 117 117 24 35
SPIRIVA 116 102 25 43
ALLOPURINOL 109 82 26 28
LOSARTAN POTASSIUM 109 94 26 15
LANTUS 100 95 28 49
PROAIR HFA 94 55 29 38
PREDNISONE 91 88 30 40
CITALOPRAM HBR 88 88 31 17
ISOSORBIDE MONONITRATE ER 88 88 31 70
TAMSULOSIN HCL 86 73 33 25
SYNTHROID 85 74 34 41
GLIPIZIDE 85 70 34 45
DIGOXIN 78 78 36 58
GLYBURIDE 77 77 R 37 53
SPIRONOLACTONE 74 68 38 100
PRAVASTATIN SODIUM 73 73 39 14
CARVEDILOL 71 59 40 73
CIPROFLOXACIN HCL 70 66 41 71
LOVASTATIN 69 69 42 24
KLOR-CON 10 69 67 42 158
ZOLPIDEM TARTRATE 68 52 44 23
SINGULAIR 67 63 45 113
DIOVAN 66 66 46 26
ACETAMINOPHEN-CODEINE 65 39 S3 47 142
ESCITALOPRAM OXALATE 64 58 48 66
CEPHALEXIN 63 52 49 130
FLUTICASONE PROPIONATE 62 47 50 34
PAROXETINE HCL 60 54 51 46
LIDODERM 59 59 52 82
KLOR-CON M10 59 59 52 162
HUMALOG 53 49 54 153
NEXIUM 52 43 55 56
BUSPIRONE HCL 51 51 56 129
DIVALPROEX SODIUM 50 50 57 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.